Historie von Umsatz, Gewinn und Cashflow aus den offiziellen Geschäftsberichten.
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.
Interaktive Charts und vollständige Abschlüsse ansehen → Bewertungsmodell (DCF) →
| Gewinn- und Verlustrechnung | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gesamtumsatz | $22.2B | $21.3B | $20.7B | $20.5B | $19.2B | $19.5B | $17.6B | $18.5B | $18.3B | $19.2B | $19.6B | $18.6B | $16.6B | $11.1B | $9.1B | $8.7B | $8.3B | $9.0B | $8.6B | $8.1B | $8.5B |
| Bruttoergebnis | — | $17.5B | $8.2B | $7.8B | $7.0B | $7.3B | $6.2B | $6.7B | $6.7B | $6.8B | $7.1B | $6.7B | $6.0B | $3.9B | $3.3B | $7.1B | $6.7B | $3.6B | $3.3B | $3.1B | $3.1B |
| Bruttomarge % | — | 82.3% | 39.7% | 38.0% | 36.8% | 37.3% | 35.3% | 36.3% | 36.4% | 35.4% | 36.4% | 35.9% | 35.8% | 35.5% | 36.3% | 82.1% | 81.3% | 39.8% | 38.4% | 37.9% | 37.2% |
| Betriebsergebnis (EBIT) | — | $3.4B | $6.0B | $2.5B | $2.3B | $2.9B | $2.0B | $1.5B | $1.6B | $1.1B | $1.2B | $1.1B | $925M | $663M | $749M | $653M | $634M | $596M | $2.3B | $2.2B | ($732M) |
| Operative Marge % | — | 16.1% | 28.8% | 12.2% | 12.2% | 14.7% | 11.3% | 8.3% | 8.9% | 5.8% | 6.4% | 5.8% | 5.6% | 6.0% | 8.2% | 7.5% | 7.7% | 6.6% | 26.7% | 26.9% | -8.7% |
| Jahresüberschuss | $2.2B | $1.4B | $3.2B | $611M | $411M | $914M | $399M | ($215M) | $104M | ($704M) | ($192M) | ($140M) | $12M | ($134M) | $152M | $82M | $1.1B | $187M | $25M | ($89M) | ($803M) |
| Nettomarge % | 10.1% | 6.6% | 15.5% | 3.0% | 2.1% | 4.7% | 2.3% | -1.2% | 0.6% | -3.7% | -1.0% | -0.8% | 0.1% | -1.2% | 1.7% | 0.9% | 13.8% | 2.1% | 0.3% | -1.1% | -9.5% |
| EBITDA | — | $4.5B | $6.9B | $3.4B | $3.1B | $3.7B | $2.5B | $2.2B | $2.4B | $1.8B | $2.1B | $1.9B | $1.8B | $861M | $1.2B | $937M | $962M | $1.1B | $843M | $659M | ($395M) |
| Ergebnis je Aktie (EPS) | $25.93 | $15.49 | $32.69 | $5.83 | $3.72 | $8.42 | $3.75 | $-2.08 | $1.00 | $-7.00 | $-1.93 | $-1.41 | $0.12 | $-1.32 | $1.40 | $0.68 | $8.16 | $1.47 | $0.21 | $-0.75 | $-6.82 |
| Ausstehende Aktien (Mio.) | — | 91M | 98M | 105M | 111M | 109M | 106M | 103M | 104M | 101M | 99M | 99M | 100M | 102M | 109M | 121M | 140M | 127M | 120M | 118M | 118M |
Quelle: veröffentlichte Unternehmensberichte (SEC). Bitte prüfen Sie die Zahlen vor Verwendung auf SEC EDGAR.
Bilanzen, Cashflow-Rechnungen, Quartalsdaten und alle Kennzahlen finden Sie im interaktiven Viewer für THC. /companies/us/THC
Die Informationen auf dieser Website dienen ausschließlich Bildungs- und Informationszwecken und stellen keine Anlageberatung dar. Es werden keine Kursziele und keine Anlageurteile veröffentlicht.
About TickerBase · Data methodology & sources · Privacy · Terms